ABO Energy’s Summer of Reckoning: Three Key Dates Before the July Financing Cliff

ABO Energy projects €170M net loss for 2025, double prior estimate, due to delayed sales and write-downs. Restructuring report affirms viability but financing deal needed by July.

ABO Energy has more than doubled its loss forecast for 2025, now projecting a net shortfall of roughly €170 million compared to an earlier estimate of €95 million. Delayed rights sales on German wind and battery projects, combined with write-downs triggered by shifting market conditions, are to blame. The return to black — at least on an EBITDA basis — has been pushed back to 2027.

Yet the company is not standing still. In May it entered the German wind auction with over 150 megawatts of capacity and secured a tariff for the 7.8 MWp solar park Birkholz in Brandenburg. Two wind farm sales in Rhineland-Palatinate, including a 4.5 MW facility due online in autumn 2026, are adding cash. Project disposals have become the primary tool for stabilising the balance sheet while the broader restructuring plays out.

A conditional clean bill of health

A first draft of the restructuring report, dated 12 May, confirms that ABO Energy is fundamentally capable of being turned around — but with a critical caveat: a viable financing agreement with creditors must still be struck. A standstill arrangement with major lenders provides cover until the end of July. If no deal is reached by then, the pressure will intensify sharply. The company acknowledges that the current resources are insufficient to fund its long-term ambition of transforming from a pure project developer into an independent power producer with its own assets and direct power marketing — a goal underpinned by a development pipeline of 34 gigawatts.

On the political front, all 16 German states at the Norderney energy ministers’ conference rejected proposed reform plans by Economy Minister Katherina Reiche that included a redispatch reservation. The unanimous opposition offers some policy clarity, but the looming gap in EEG subsidies from January 2027 remains unresolved. For a company in the middle of restructuring that depends on tariff premiums and project sales, the lack of a follow-up regime complicates financial planning.

A trio of milestones before the summer ends

The coming months are framed by three specific dates that will test the turnaround story. On 22 June, the audited 2025 annual accounts are due. If they show that project sales have stabilised cash reserves, investor confidence could improve ahead of the shareholder assembly. That assembly takes place in Wiesbaden on 13 August — an extraordinary meeting made necessary because half of the company’s share capital has been wiped out. Management will update investors on the restructuring progress and the financing negotiations. Then on 1 September, the half-year 2026 figures will land, providing the first full operational read on whether the turnaround is gaining traction.

The stock, which briefly crossed above its 38-day moving average on 18 May, still trades 66.83% below the 200-day line. Since August 2025, the shares have lost roughly 85% of their value. If a credible financing package does not emerge before the end of July, the five-year low of €4.25 will come back into sharp focus.